Alan Levine, CEO of Ballad Health, talked to a group at Health:Further on Aug. 29 about how, and why, the newly merged health system wants to rethink the way people get care in East Tennessee.
The number of Tennesseans who died from drug overdoses hit another record high in 2017, continuing a troubling trend that’s plagued the state for nearly a decade.
Measures to reduce the number of opioid prescriptions, such as hydrocodone and oxycontin, have started to take hold across the state, as illustrated above in an analysis from the Sycamore Institute.
But, the number of people who died from opioid overdoses jumped year over year, in part from a surge in deaths from illicit drugs, according to new data from the Tennessee Department of Health.
This is the first in an on-going series that will look at a wide range of issues, including the economy, infrastructure and manufacturing, facing Tennessee’s next governor.
The deal is a byproduct of excess private equity funds sitting around and the stresses piling up on public health care companies — and “quarter-to-quarter obsessions aren’t ideal for turning the battleship.”
The Mental Health Marketing conference, in its third year, puts the spotlight on how companies can more effectively reach the people who need such treatment.
Some of Nashville’s successful (and now former) health care entrepreneurs share mistakes they made in the early days of building their company.
Health:Further’s David Shifrin invited me on ‘The Future of Health’ podcast to talk about the BirdDog experiment and Nashville’s health care industry from an observer’s perspective.